The study that led the U.N.’s World Health Organization (W.H.O.) to halt clinical trials of the drug hydroxychloroquine (HCQ) as a treatment for the infection caused by the Chinese coronavirus has been called into question..
..In a column at the Association of American Physicians and Surgeons, Dr. Elizabeth Lee Vliet, wrote of the significance of HCQ, coupled with zinc, to be used at early onset of COVID-19 symptoms.
“More studies have replicated these findings,” she explained. “HCQ given within the first week of symptoms, especially with zinc, can prevent the virus from entering your body’s cells and taking over, much like people use locks and alarms to stop burglaries”..
WHO benefits from the halt of clinical trials of HCQ and the restrictions on its use?
